WallStSmart

Medtronic PLC (MDT)vsPAVmed Inc (PAVM)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Medtronic PLC generates 122358521% more annual revenue ($35.48B vs $29,000). PAVM leads profitability with a 106.7% profit margin vs 13.0%. MDT earns a higher WallStSmart Score of 56/100 (C).

MDT

Buy

56

out of 100

Grade: C

Growth: 4.0Profit: 6.5Value: 7.3Quality: 5.0

PAVM

Hold

35

out of 100

Grade: F

Growth: 5.3Profit: 5.5Value: 5.0Quality: 5.0
Piotroski: 4/9Altman Z: -9.78
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

MDTSignificantly Overvalued (-255.7%)

Margin of Safety

-255.7%

Fair Value

$24.34

Current Price

$86.58

$62.24 premium

UndervaluedFair: $24.34Overvalued

Intrinsic value data unavailable for PAVM.

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

MDT4 strengths · Avg: 8.3/10
Market CapQuality
$110.62B9/10

Large-cap with strong market position

Price/BookValuation
2.3x8/10

Reasonable price relative to book value

Operating MarginProfitability
20.0%8/10

Strong operational efficiency at 20.0%

Free Cash FlowQuality
$2.30B8/10

Generating 2.3B in free cash flow

PAVM3 strengths · Avg: 9.7/10
Price/BookValuation
0.8x10/10

Reasonable price relative to book value

Profit MarginProfitability
106.7%10/10

Keeps 107 of every $100 in revenue as profit

Debt/EquityHealth
0.269/10

Conservative balance sheet, low leverage

Areas to Watch

MDT1 concerns · Avg: 2.0/10
EPS GrowthGrowth
-11.8%2/10

Earnings declined 11.8%

PAVM4 concerns · Avg: 2.8/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$9.06M3/10

Smaller company, higher risk/reward

Revenue GrowthGrowth
-99.5%2/10

Revenue declined 99.5%

Free Cash FlowQuality
$-899,0002/10

Negative free cash flow — burning cash

Comparative Analysis Report

WallStSmart Research

Bull Case : MDT

The strongest argument for MDT centers on Market Cap, Price/Book, Operating Margin.

Bull Case : PAVM

The strongest argument for PAVM centers on Price/Book, Profit Margin, Debt/Equity. Profitability is solid with margins at 106.7% and operating margin at -968.8%.

Bear Case : MDT

The primary concerns for MDT are EPS Growth.

Bear Case : PAVM

The primary concerns for PAVM are EPS Growth, Market Cap, Revenue Growth.

Key Dynamics to Monitor

MDT profiles as a value stock while PAVM is a declining play — different risk/reward profiles.

PAVM carries more volatility with a beta of 0.88 — expect wider price swings.

MDT is growing revenue faster at 8.7% — sustainability is the question.

MDT generates stronger free cash flow (2.3B), providing more financial flexibility.

Bottom Line

MDT scores higher overall (56/100 vs 35/100). Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Medtronic PLC

HEALTHCARE · MEDICAL DEVICES · USA

Medtronic plc is an American-Irish registered medical device company that primarily operates in the United States. Medtronic has an operational and executive headquarters in Fridley, Minnesota in the US.

PAVmed Inc

HEALTHCARE · MEDICAL DEVICES · USA

PAVmed Inc. is a medical device company in the United States. The company is headquartered in New York, New York.

Visit Website →

Want to dig deeper into these stocks?